CEO - Cann Group, Chair - Medicinal Cannabis Industry Australia
Drawing on nearly three decades experience at global agribusiness Nufarm (ASX: NUF), Cann Group’s CEO Peter Crock is helping to shape the future of the medicinal cannabis industry in Australia. With Peter at the helm and working closely with an experienced board of directors, Cann Group (ASX: CAN) received the first commercial cultivation licence in Australia, and was the first medicinal cannabis company to successfully list via an Initial Public Offering (IPO) on the Australian Securities Exchange (ASX), raising AUD$13.5 million in shareholder capital.
To accelerate organisational growth, Cann Group completed an additional AUD$70m capital raise, which has enabled the advancement of its’ most ambitious project to date; a controlled environment, automated production facility which will be able to produce 70,000kg of medicinal cannabis products per year when at full capacity. With deep knowledge and experience in the areas marketing, business and technology development, as well as mergers and acquisitions, Peter has overseen the growth and advancement of Cann Group.